ConductScience.org, home

Paper36744872

Effectiveness and safety of rectal dexibuprofen versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants with gestational age<34 weeks: A pilot study.

Pan JJ and 4 others. Int J Immunopathol Pharmacol, 2023. Cited by 2 papers, by iCite.

Cite this record

ConductScience Library. Effectiveness and safety of rectal dexibuprofen versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants with gestational age<34 weeks: A pilot study. Papers, record 36744872. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36744872

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Effectiveness and safety of rectal dexibuprofen versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants with gestational age<34 weeks: A pilot study.
PubMed
Journal
Int J Immunopathol Pharmacol
PubMed
Year
2023
PubMed
Publication types
Journal Article, Randomized Controlled Trial
PubMed
Citations, by iCite
2
iCite
Relative citation ratio, by iCite
0.2
iCite
Revised in PubMed
2026-01-27
PubMed

Authors5

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Pan JJJing-Jing
2Yang YYanghttps://orcid.org/0000-0002-0610-7197
3Cui SDShu-Dong
4Chen XQXiao-Qing
5Zhou XGXiao-Guang

Source PubMed

Download CSV of authors

Topics9

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Ductus Arteriosus, PatentMajor topic
Infant, PrematureMajor topic
Humans
Infant
Infant, Newborn
Gestational Age
Ibuprofen
Infant, Low Birth Weight
Pilot Projects

Source PubMed

Download CSV of topics

References38

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
16338474Evaluation of the preterm infant for patent ductus arteriosus.Pediatrics1983https://conductscience.org/library/papers/6338474PubMed
223544808Comparison of oral Ibuprofen and intravenous indomethacin for the treatment of patent ductus arteriosus in extremely low birth weight infants.J Pediatr (Rio J)2013https://conductscience.org/library/papers/23544808PubMed
328206995Patent ductus arteriosus in premature infants: to treat or not to treat?J Perinatol2017https://conductscience.org/library/papers/28206995PubMed
47082044Simple estimate of creatinine clearance from plasma creatinine in neonates.Arch Dis Child1982https://conductscience.org/library/papers/7082044PubMed
529695206Efficacy and safety of oral paracetamol versus oral ibuprofen for closure of patent ductus arteriosus in preterm infants: a randomized controlled trial.J Matern Fetal Neonatal Med2019https://conductscience.org/library/papers/29695206PubMed
631985838Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.Cochrane Database Syst Rev2020https://conductscience.org/library/papers/31985838PubMed
732498576IVF/ICSI treatment and the risk of iatrogenic preterm birth in singleton pregnancies: systematic review and meta-analysis of cohort studies.J Matern Fetal Neonatal Med2022https://conductscience.org/library/papers/32498576PubMed
823054725Comparative evaluation for the use of oral ibuprofen and intravenous indomethacin in Korean infants with patent ductus.Arch Pharm Res2012https://conductscience.org/library/papers/23054725PubMed
923238355Oral versus rectal ibuprofen in healthy volunteers.J Popul Ther Clin Pharmacol2012https://conductscience.org/library/papers/23238355PubMed
1016770073Mechanisms regulating the ductus arteriosus.Biol Neonate2006https://conductscience.org/library/papers/16770073PubMed
11413500Neonatal necrotizing enterocolitis. Therapeutic decisions based upon clinical staging.Ann Surg1978https://conductscience.org/library/papers/413500PubMed
1211771569Overview on clinical data of dexibuprofen.Clin Rheumatol2001https://conductscience.org/library/papers/11771569PubMed
1320335313CONSORT 2010 statement: updated guidelines for reporting parallel group randomized trials.Ann Intern Med2010https://conductscience.org/library/papers/20335313PubMed
1424317704A randomised placebo-controlled trial of early treatment of the patent ductus arteriosus.Arch Dis Child Fetal Neonatal Ed2014https://conductscience.org/library/papers/24317704PubMed
1530850756Comparative effectiveness of drugs used to constrict the patent ductus arteriosus: a secondary analysis of the PDA-TOLERATE trial (NCT01958320).J Perinatol2019https://conductscience.org/library/papers/30850756PubMed
1630423323Clinical outcomes after more conservative management of patent ductus arteriosus in preterm infants.J Pediatr (Rio J)2020https://conductscience.org/library/papers/30423323PubMed
17305471Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm.J Pediatr1978https://conductscience.org/library/papers/305471PubMed
1832045960Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.Cochrane Database Syst Rev2020https://conductscience.org/library/papers/32045960PubMed
1916650652Bronchopulmonary dysplasia.Lancet2006https://conductscience.org/library/papers/16650652PubMed
2019387684Does echocardiography facilitate determination of hemodynamic significance attributable to the ductus arteriosus?Eur J Pediatr2009https://conductscience.org/library/papers/19387684PubMed

See all 38 referencesDownload CSV of references

Cited by2

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 2 citations.

PMIDTitleJournalYearIn PapersSource
40737428Impairment of stromal-epithelial regenerative cross-talk in Hirschsprung disease primes for the progression to enterocolitis.Sci Transl Med2025https://conductscience.org/library/papers/40737428PubMed
40240526Heterogeneity in treatment response for patent ductus arteriosus: a meta-analysis.Eur J Pediatr2025https://conductscience.org/library/papers/40240526PubMed

Download CSV of cited by

Genes4

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
CMPK151727PubTator's text mininghttps://conductscience.org/library/genes/51727NCBI Gene
CST31471PubTator's text mininghttps://conductscience.org/library/genes/1471NCBI Gene
GPT2875PubTator's text mininghttps://conductscience.org/library/genes/2875NCBI Gene
RBP45950PubTator's text mininghttps://conductscience.org/library/genes/5950NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/36744872

GET https://conductscience.org/api/papers/v1/36744872/references?page=2